Novartis_FBO_Posting.docx

The Centers for Disease Control and Prevention, NCIRD/ISD, 1600 Clifton Rd. NE, Mailstop A19, Atlanta, GA, 30333, hereby announces its intent to issue a sole source contract to Novartis Vaccines and Diagnostics 350 Massachusetts Ave Cambridge, MA 02139 to increase the target quantities of the Fluvirin vaccine.

NAICS Code: 325412

Period of Performance: 12/18/2015 to 12/17/2016

The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 13.106-1(b)(1)(i). CDC needs to modify its contract to expand the maximum doses available to meet increased demand of Fluvirin vaccine. CDC has no other contract with an equivalent vaccine to meet this demand.

Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency for future procurement. Please forward the capability statement and/or pricing information to Michael Harwell, Contracting Specialist, Reference 200-2016-88486, Centers for Disease Control, Office of Acquisition Services, ATTN: Michael Harwell, MS: K14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov.

This is a posting of a sole source award to Novartis Vaccines and Diagnostics and is not a request for competition.